Acute intermittent hypercapnia-based interventions for upper airway and axial control in Parkinsonism
Official title: A Pilot Study of Acute Intermittent Hypercapnia-Based Interventions on Upper Airway and Axial Motor Function in Parkinson's Disease
Run by University of Florida · NCT07674264 · Data updated 2026-11-12
This randomized pilot study tests whether a single session of acute intermittent hypercapnic hypoxia or hypercapnic normoxia can improve upper airway and axial motor function in adults with Parkinsonism.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 2 sites (Gainesville, Florida and 1 other locations) |
| Status | Recruiting |
| Started | August 12, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07674264 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–75 with idiopathic Parkinsonism (Hoehn and Yahr stages 2–4), medically stable, able to walk at least 10 feet, and able to follow directions.
✕Probably not a fit
Individuals with additional neurologic conditions, uncontrolled cardiovascular issues, or deep brain stimulation implants may not benefit or participate safely.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional pilot trial explores whether brief exposure to controlled levels of CO2-related breathing challenges can improve breathing-related and axial motor function in Parkinsonism. Participants will be randomized to receive either acute intermittent hypercapnic hypoxia (AIHH) or acute intermittent hypercapnic normoxia (AIHN) in a single session. The study looks for changes in upper airway control, axial motor performance, and related biomarkers to understand who may respond best. Safety monitoring and feasibility of this approach will also be evaluated. The trial is conducted at the University of Florida and the Norman Fixel Institute, with adults aged 40 to 75 years who have idiopathic Parkinsonism and meet eligibility criteria.
Why it matters
Potential benefit: If successful, the intervention could improve breathing, speech volume, and cough effectiveness in people with Parkinsonism.
How similar studies have gone: Prior work in related respiratory-nerve and motor-function domains has shown feasibility with hypercapnic interventions, but this exact protocol for Parkinsonism is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. adults 40 to 75 years of age (the latter to reduce the likelihood of cardiovascular disease) 2. diagnosis of idiopathic Parkinsonism with Hoehn and Yahr stages 2-4 3. medically stable with physician clearance 4. ability to ambulate at least 10 feet with/without assistance 5. ability to follow directions 6. willing to abstain from blood donation for the duration of the study Exclusion Criteria: 1. additional neurologic conditions 2. severe illness or infection, including respiratory/cardiovascular/lung disease, or uncontrolled hypertension 3. inspiratory stridor 4. pregnancy due to unknown tAIH effects on a fetus, although females of childbearing age will not be excluded\* 5. cigarette smoking or vaping within 5 years 6. history of head/neck/lung cancer with the exception of basal cell carcinoma 7. is currently participating in another research study that could influence the results from this study 8. has deep brain stimulation electrodes implanted or has a history of deep brain stimulation 9. faints or becomes lightheaded at the sight of blood * If a female of childbearing potential indicates there is a chance she could be pregnant, she will be provided a pregnancy test and allowed to continue in the study if negative. This is because the fetal risks associated with intermittent hypoxia are unknown.
Where it's running
-
University of Florida
Gainesville, Florida, United States Recruiting -
Norman Fixel Institute for Neurological Diseases
Gainesville, Florida, United States Recruiting
Study contacts
- Principal investigator: Michela Mir, CCC-SLP — University of Florida
- Study coordinator: Michlela Mir, CCC-SLP, PhD
- Email: michela.mir@ufl.edu
- Phone: 352-273-6095
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Complementary medicine clinic care for people with Parkinson's in London
This project will collect routine clinic data and questionnaires to see if complementary therapies help people with Parkinson's who attend a London charitable clinic.
-
Using saliva and extracellular vesicles to diagnose neurodegenerative diseases
This study is testing a new way to diagnose neurodegenerative diseases like Alzheimer's and Parkinson's by analyzing saliva samples to see if it can help identify these conditions earlier and tailor treatments for patients.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.